{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:29:55Z","timestamp":1757705395458},"reference-count":13,"publisher":"Discover STM Publishing Ltd.","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.sudanjp.com\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sudan J Paed"],"abstract":"<jats:p>In nocturnal enuresis motivational therapy, alarm therapy and drug therapy such as anticholinergics, imipramine and sertraline are the mainstay of treatment. In this study, we used motivational therapy, oxybutynin and propranolol in children with primary nocturnal enuresis to determine if propranolol is effective in the treatment of primary nocturnal enuresis. Fifty two children with primary nocturnal enuresis were included in the study. Firstly, motivational motivational therapy was given for 1 month in all patients. Patients who failed by motivational therapy were randomly given oxybutynin or propranolol. The patients were re-evaluated after 1 month of drug therapy. There was not a significant difference between oxybutynin and propranolol groups for initial frequency of nocturnal enuresis (P &amp;gt;0.05). Of 52 patients, 28 (53.8%) patients were improved by motivational therapy. There were 14 patients in oxybutynin group. One patient was excluded from the study because facial flushing and mouth drying developed in the first week of oxybutynin therapy. In oxybutynin group, 12 (92.3%) of 13 patients were improved. There were 10 patients in propranolol group. In propranolol group, while nine (90%) patients were not improved, one patient had significant remission (90%) (P <\/jats:p>","DOI":"10.24911\/sjp.106-1536134988","type":"journal-article","created":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T06:26:31Z","timestamp":1546323991000},"page":"33-36","source":"Crossref","is-referenced-by-count":3,"title":["Use of propranolol in children with primary nocturnal enuresis"],"prefix":"10.24911","author":[{"given":"Huseyin","family":"Caksen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Yazicioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Atas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10538","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Haid B, Tekg\u00fcl S. Primary and secondary enuresis: pathophysiology, diagnosis, and treatment. Eur Urol Focus. 2017;3:198-206. https:\/\/doi.org\/10.1016\/j.euf.2017.08.010","DOI":"10.1016\/j.euf.2017.08.010"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Franco I, von Gontard A, De Gennaro M. International Children's Continence Society. Evaluation and treatment of nonmonosymptomatic nocturnal enuresis: a standardization document from the international children's continence society. J Pediatr Urol. 2013;9:234-43. https:\/\/doi.org\/10.1016\/j.jpurol.2012.10.026","DOI":"10.1016\/j.jpurol.2012.10.026"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Jain S, Bhatt GC. Advances in the management of primary monosymptomatic nocturnal enuresis in children. Paediatr Int Child Health. 2016;36:7-14. https:\/\/doi.org\/10.1179\/2046905515Y.0000000023","DOI":"10.1179\/2046905515Y.0000000023"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Neveus T, Eggert P, Evans J, Macedo A, Rittig S, Tekgul S, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children's Continence Society. J Urol. 2010;183:441-7. https:\/\/doi.org\/10.1016\/j.juro.2009.10.043","DOI":"10.1016\/j.juro.2009.10.043"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Bolat D, Acar IC, Zumrutbas AE, Eskicorapci S, Sancak EB, Zencir M, et al. Prevalence of daytime urinary incontinence and related risk factors in primary school children in Turkey. Korean J Urol. 2014;55:213-8. https:\/\/doi.org\/10.4111\/kju.2014.55.3.213","DOI":"10.4111\/kju.2014.55.3.213"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Deshpande AV, Caldwell PH, Sureshkumar P. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database Syst Rev. 2012;12:CD002238. https:\/\/doi.org\/10.1002\/14651858.CD002238.pub2","DOI":"10.1002\/14651858.CD002238.pub2"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5694\/j.1326-5377.1975.tb111436.x","article-title":"Letter: Alpranenolol and enuresis","volume":"1","author":"Lake","year":"1975","unstructured":"Lake B. Letter: Alpranenolol and enuresis. Med J Aus. 1975;1:367.","journal-title":"Med J Aus"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Stoffer SS. Loss of bladder control in hyperthyroidism. Postgrad Med. 1988;84:117-8. https:\/\/doi.org\/10.1080\/00325481.1988.11700513","DOI":"10.1080\/00325481.1988.11700513"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Meir J, Roessner D, Eggert P. Enuresis in hyperthyroidism: a temporary lack of central control mechanism leads to nocturnal enuresis. Acta Paediatr. 2010;99:145-6.","DOI":"10.1111\/j.1651-2227.2009.01511.x"},{"key":"ref9","unstructured":"Naglo AS, Bor\u00e9us LO, Hellstr\u00f6m B, Nerg\u00e5rdh A. Is beta-receptor blockade of value in continence training of children? Scand J Rehabil Med. 1979;11:63-6."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Walter S, Colstrup H, Kristensen JK. Adult enuresis and hyperthyroidism. Urology. 1983;22:151-2. https:\/\/doi.org\/10.1016\/0090-4295(83)90497-1","DOI":"10.1016\/0090-4295(83)90497-1"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Lin J, Rodrigues Masruha M, Prieto Peres MF, Cianciarullo Minett TS, de Souza Vitalle MS, Amado Scerni D, et al. Nocturnal enuresis antecedent is common in adolescents with migraine. Eur Neurol. 2012;67:354-9. https:\/\/doi.org\/10.1159\/000336055","DOI":"10.1159\/000336055"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Carotenuto M, Esposito M, Pascotto A. Migraine and enuresis in children: an unusual correlation? Med Hypotheses. 2010;75:120-2. https:\/\/doi.org\/10.1016\/j.mehy.2010.02.004","DOI":"10.1016\/j.mehy.2010.02.004"}],"container-title":["Sudanese Journal of Paediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.ejmanager.com\/fulltextpdf.php?mno=6816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T18:22:16Z","timestamp":1680805336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/fulltextpdf.php?mno=6816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":13,"URL":"https:\/\/doi.org\/10.24911\/sjp.106-1536134988","relation":{},"ISSN":["0256-4408"],"issn-type":[{"value":"0256-4408","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}